Clearstead Advisors’s BRAINSTORM CELL THERAPUTC BCLI Stock Holding History

Clearstead Advisors’s Portfolio BCLI Stock Details BCLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$112	Hold
2025 Q1	$126	Hold
2024 Q4	$227	Hold
2024 Q3	$346	Hold
2024 Q2	$508	Hold
2024 Q1	$822	Buy